Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany (vol 17, e0278460, 2022)

被引：0
|
作者：
Schwarz, Florian [1 ]
Arefian, Habibollah [1 ]
Hartmann, Michael [1 ]
Runnebaum, Ingo [1 ]
机构：
[1] Canc Ctr Cent Germany, Jena, Germany
来源：
PLOS ONE | 2024年 / 19卷 / 05期
关键词：
D O I：
10.1371/journal.pone.0303776
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast Cancer
    Nguyen, Trang T. H.
    Mital, Shweta
    PHARMACOECONOMICS, 2025, 43 (03) : 351 - 361
  • [32] Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer
    Hashemi-Meshkini, Amir
    Keshavarz, Khosro
    Gharibnaseri, Zahra
    Kheirandish, Mehrnaz
    Kebriaeezadeh, Abbas
    Nikfar, Shekoufeh
    Abdollahi, Mohammad
    ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (03) : 472 - 478
  • [33] Cost-effectiveness analysis of exemestane compared with megestrol in patients with advanced breast carcinoma
    Hillner, BE
    Radice, D
    CANCER, 2001, 91 (03) : 484 - 489
  • [34] Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer
    Lee, Jung-Yun
    Kim, Younhee
    Lee, Tae-Jin
    Jeon, Yong Woo
    Kim, Kidong
    Chung, Hyun Hoon
    Kim, Hak Jae
    Park, Sang Min
    Kim, Jae-Weon
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2015, 26 (03) : 171 - 178
  • [35] Is it time to incorporate lymphadenectomy into the primary management of locally advanced cervical cancer? A cost-effectiveness analysis
    Resnick, K.
    Cohn, D.
    Martin, D.
    Bussewitz, E.
    Straughn, J.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S19 - S19
  • [36] Cost-effectiveness of open vs. laparoscopic gastrectomy for locally advanced gastric cancer in China
    Lai, Min
    Li, Yanting
    Lan, Ning
    Yuan, Wenzhen
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [37] COST-EFFECTIVENESS ANALYSIS: SELECTIVE USE OF NEOADJUVANT CHEMORADIATION IN LOCALLY ADVANCED RECTAL CANCER.
    Mueller, A. N.
    Torgersen, Z. N.
    Shashidharan, M.
    Ternent, C. A.
    DISEASES OF THE COLON & RECTUM, 2022, 65 (05) : 35 - 35
  • [38] COST-EFFECTIVENESS OF PARA-AORTIC LYMPHADENECTOMY BEFORE CHEMORADIOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER
    Lee, J. Y.
    Kim, J. W.
    VALUE IN HEALTH, 2014, 17 (07) : A735 - A736
  • [39] A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
    Sun, Li
    Brentnall, Adam
    Patel, Shreeya
    Buist, Diana S. M.
    Bowles, Erin J. A.
    Evans, D. Gareth R.
    Eccles, Diana
    Hopper, John
    Li, Shuai
    Southey, Melissa
    Duffy, Stephen
    Cuzick, Jack
    dos Santos Silva, Isabel
    Miners, Alec
    Sadique, Zia
    Yang, Li
    Legood, Rosa
    Manchanda, Ranjit
    JAMA ONCOLOGY, 2019, 5 (12) : 1718 - 1730
  • [40] Cost-effectiveness Analysis of Pertuzumab With Trastuzumab in Patients With Metastatic Breast Cancer
    Dai, Wei Fang
    Beca, Jaclyn M.
    Nagamuthu, Chenthila
    Liu, Ning
    de Oliveira, Claire
    Earle, Craig C.
    Trudeau, Maureen
    Chan, Kelvin K. W.
    JAMA ONCOLOGY, 2022, 8 (04) : 597 - 606
12345